Glucarpidase (reduce toxic plasma methotrexate concentration in adults and children aged ≥ 28 days)

Subject:

• Active Substance: Glucarpidase
• Name: Voraxaze^®
• Therapeutic area: Toxic methotrexate plasma concentration
• Pharmaceutical company: SERB GmbH

Time table:

• Start: 15.04.2022
• Final decision by G-BA: 06.10.2022

Final decision:

• Hint for a non-quantifiable additional benefit